Cara Therapeutics Inc (CARA)

Feb 07, 2025

Cara Therapeutics CEO Christopher Posner sells $1,755 in stock By Investing.com - Investing.com South Africa

Feb 07, 2025

Feb 07, 2025

Cara Therapeutics CEO Christopher Posner sells $1,755 in stock - MSN

Feb 07, 2025

Feb 07, 2025

Cara Therapeutics CEO Posner sells shares worth $1,755 - MSN

Feb 07, 2025

Feb 06, 2025

Cara Therapeutics CEO Posner sells shares worth $1,755 By Investing.com - Investing.com Nigeria

Feb 06, 2025

Jan 27, 2025

Cara Therapeutics 8-K SEC Filing Reveals Merger Plans with Tvardi Therapeutics - Defense World

Jan 27, 2025

Jan 24, 2025

Cara Therapeutics, Inc. (NASDAQ:CARA) Receives Average Rating of “Hold” from Brokerages - Defense World

Jan 24, 2025

Jan 21, 2025

Cara Therapeutics Announces Merger with Tvardi Therapeutics - TipRanks

Jan 21, 2025

Jan 18, 2025

Cara Therapeutics regains Nasdaq compliance - MSN

Jan 18, 2025

Jan 15, 2025

Midday Market Movers: Biggest Stock Declines of the Day – Market - HPBL

Jan 15, 2025

Jan 09, 2025

Cara Therapeutics Shares Surge 20% After 1-for-20 Reverse Stock Split – Market - HPBL

Jan 09, 2025

Jan 08, 2025

Cara Therapeutics (NASDAQ:CARA) Coverage Initiated at StockNews.com - Defense World

Jan 08, 2025

Jan 07, 2025

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ML, PWOD, NURO, CARA on Behalf of Shareholders - The Malaysian Reserve

Jan 07, 2025

Jan 06, 2025

CARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cara Therapeutics, Inc.CARA - Business Wire

Jan 06, 2025

Jan 02, 2025

Cara Therapeutics Files Certificate of Amendment for Reverse Stock Split and Shares Reduction - Defense World

Jan 02, 2025

Jan 01, 2025

Cara shares jump 32% following reverse stock split - MSN

Jan 01, 2025

Jan 01, 2025

Cara Therapeutics, Inc. Announces Appointment of Joseph Stauffer as Chief Medical Officer - Marketscreener.com

Jan 01, 2025

Jan 01, 2025

Cara Therapeutics, Inc. Announces Outcome from Dose- Finding Part A of the KIND 1 Study Evaluating Oral Difelikefalin for Mod Moderate-To-Severe Pruritus in Patients with Atopic Dermatitis - Marketscreener.com

Jan 01, 2025

Jan 01, 2025

Cara Therapeutics discontinues neurological condition study as drug fails - Marketscreener.com

Jan 01, 2025

Jan 01, 2025

Cara: Q2 Earnings Snapshot - Marketscreener.com

Jan 01, 2025

Dec 31, 2024

Cara Therapeutics stock hits 52-week high at $4.26 By Investing.com - Investing.com Nigeria

Dec 31, 2024

Dec 31, 2024

Cara Therapeutics Shares Rise 20% Following Reverse Stock Split - MarketWatch

Dec 31, 2024

Dec 31, 2024

Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn

Dec 31, 2024

Dec 31, 2024

Stock market news: Coeptis Therapeutics Holdings declined by 96.03% whereas Baird Medical Investment Holdings +496.89% during mid day trading - Business Upturn

Dec 31, 2024

Dec 31, 2024

Stock market today: Coeptis Therapeutics Holdings -95.79%, OptiNose -93.64% among biggest losers in early trading - Business Upturn

Dec 31, 2024

Dec 31, 2024

Stock market today: Coeptis Therapeutics Holdings plunged by 95.98% whereas Baird Medical Investment Holdings gained over 201.90% in early trading - Business Upturn

Dec 31, 2024

Dec 31, 2024

Cara Therapeutics stock hits 52-week high at $4.26 - Investing.com India

Dec 31, 2024

Dec 30, 2024

Cara to cut 50% of workforce, end CKD program to extend cash runway to 2026 - MSN

Dec 30, 2024

Dec 30, 2024

Cara Therapeutics announces effective date for 1-for-12 reverse stock split - Hartford Business Journal

Dec 30, 2024

Dec 30, 2024

Cara Therapeutics, Inc. (NASDAQ:CARA) Given Average Rating of “Hold” by Brokerages - Defense World

Dec 30, 2024

Dec 28, 2024

Cara Therapeutics announces 1-for-12 reverse stock split to regain Nasdaq compliance - MSN

Dec 28, 2024

Dec 27, 2024

Cara Therapeutics to Implement 1-for-12 Reverse Stock Split - Marketscreener.com

Dec 27, 2024

Dec 27, 2024

Cara Therapeutics enacts reverse stock split - Investing.com

Dec 27, 2024

Dec 27, 2024

Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split - The Manila Times

Dec 27, 2024

Dec 27, 2024

Cara Therapeutics (CARA) Announces 1-for-12 Reverse Stock Split to Maintain Nasdaq Listing - StockTitan

Dec 27, 2024

Dec 25, 2024

Cara Therapeutics, Inc. (NASDAQ:CARA) Shares Bought by Fmr LLC - Defense World

Dec 25, 2024

Dec 23, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of Shareholders - The Eastern Progress Online

Dec 23, 2024

Dec 23, 2024

StockNews.com Initiates Coverage on Cara Therapeutics (NASDAQ:CARA) - Defense World

Dec 23, 2024

Dec 20, 2024

Cara Therapeutics Enters Agreement to Merge with Tvardi Therapeutics - Defense World

Dec 20, 2024

Dec 19, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ARCH on Behalf of Shareholders - GlobeNewswire

Dec 19, 2024

Dec 19, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NURO, CARA, ZUO, BMTX on Behalf of Shareholders - The Malaysian Reserve

Dec 19, 2024

Dec 18, 2024

Cara in all-stock merger deal with Tvardi - MSN

Dec 18, 2024

Dec 18, 2024

Tvardi Therapeutics to go public in reverse merger with Connecticut company - The Business Journals

Dec 18, 2024